Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
Auction 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Phase 2 Trial
Recent news which mentions Phase 2 Trial
< Previous
1
2
3
4
5
6
7
8
9
Next >
ALX Oncology's Evorpacept Data Fails To Impress At ASH Presentation
December 13, 2021
Tickers
ALXO
Tags
Health Care
Benzinga
Trading Ideas
From
Benzinga
Viracta Therapeutics Posts Data From Lymphoma Trial At ASH Presentation
December 13, 2021
Tickers
VIRX
Tags
VIRX
News
Phase 1 Trial
From
Benzinga
Harpoon Shares Jump After Early Data From BCMA-Targeting Myeloma Candidate At ASH Meet
December 13, 2021
Tickers
HARP
Tags
ASH21
Biotech
multiple myeloma
From
Benzinga
JNJ's Janssen Posts Two Years Survival Data On BCMA Cell Therapy In Multiple Myeloma
December 13, 2021
Tickers
JNJ
LEGN
Tags
Market News
Briefs
General
From
Benzinga
Jazz Posts New Data for ALL/LBL Treatment At ASH 2021 Annual Meeting
December 13, 2021
Tickers
JAZZ
Tags
Health Care
Benzinga
Phase 2 Trial
From
Benzinga
Roche Uncorks Favorable Responses From Mosunetuzumab In Follicular Lymphoma Settings
December 13, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHBF
lymphoma
General
From
Benzinga
Bluebird Bio Posts Updated Data From Sickle Cell Gene Therapy Program
December 13, 2021
Tickers
BLUE
Tags
Briefs
General
Market News
From
Benzinga
Merus Shares Updated Data From Zeno Triplet Combo Data In Breast Cancer Settings
December 10, 2021
Tickers
MRUS
Tags
Biotech
breast cancer
Health Care
From
Benzinga
Infinity Pharma Shares Updated Eganelisib Combo Therapy In Breast Cancer Trial
December 10, 2021
Tickers
BMY
INFI
RHHBF
RHHBY
Tags
BMY
Health Care
Penny Stocks
From
Benzinga
Moderna Posts Data From Early mRNA Flu Vaccine Study, Pivotal Trial On Its Way
December 10, 2021
Tickers
BNTX
MRNA
SNY
Tags
MRNA
Phase 1 Trial
News
From
Benzinga
Roche Posts Encouraging Follow-up Data From Tiragolumab/Tecentriq Trial In Lung Cancer
December 10, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHVF
General
Briefs
From
Benzinga
Angion's ANG-3777 Faces Third Failure In 2021, This Time Flunks Acute Kidney Injury Trial
December 10, 2021
Tickers
ANGN
Tags
Biotech
why it's moving
Short Ideas
From
Benzinga
Innate Pharma Says Chemo-Free Monalizumab Triplet Therapy Shows Preliminary Anti-Cancer Activity
December 09, 2021
Tickers
AZN
AZNCF
IPHA
Tags
Biotech
IPHA
Trading Ideas
From
Benzinga
Johnson & Johnson Posts Additional RSV Vaccine Data
December 07, 2021
Tickers
JNJ
Tags
Biotech
News
JNJ
From
Benzinga
Ideaya Reports New Data From Combo Therapy Regime In Pretreated Eye Cancer Patients
December 07, 2021
Tickers
IDYA
Tags
General
Briefs
Market News
From
Benzinga
Prometheus Biosciences Posts Phase 1 Data On Lead Therapeutic Candidate
December 07, 2021
Tickers
RXDX
Tags
Biotech
Health Care
Phase 2 Trial
From
Benzinga
Bellicum Secures $35M Via Equity Funding, Posts Interim Data From Early GoCAR-T Cancer Studies
December 06, 2021
Tickers
BLCM
Tags
Offerings
News
prostate cancer
From
Benzinga
Ocular Therapeutix's Dexamethasone Ophthalmic Insert Meets Primary Goal In Dry Eye Disease Trial
December 06, 2021
Tickers
OCUL
Tags
Health Care
Benzinga
Trading Ideas
From
Benzinga
GH Research Posts Data From Treatment-Resistant Depression Trial
December 06, 2021
Tickers
GHRS
Tags
Biotech
Earnings
Phase 2 Trial
From
Benzinga
Bolt Biotherapeutics Reveals Early Data From BDC-1001 Immuno-Oncology Candidate
December 06, 2021
Tickers
BOLT
Tags
BOLT
Small Cap
Phase 1 Trial
From
Benzinga
Molecular Partners' Ensovibep Shows Early Safety Profile In COVID-19
December 06, 2021
Tickers
MOLN
Tags
Phase 1 Trial
Small Cap
News
From
Benzinga
Stoke Touts Early Signs Of Efficacy For Antisense Drug In Dravet Syndrome
December 03, 2021
Tickers
STOK
Tags
General
Briefs
STOK
From
Benzinga
Kazia Unveils Final Data From Mid-Stage Paxalisib Data In Newly Diagnosed Glioblastoma Patients
December 03, 2021
Tickers
KZIA
Tags
Biotech
Benzinga
Trading Ideas
From
Benzinga
Xenon Stock Jumps On New Encouraging Data From Epilepsy Treatment
December 03, 2021
Tickers
XENE
Tags
Phase 2 Trial
Benzinga
Trading Ideas
From
Benzinga
SQZ Biotechnologies' Cell Therapy Shows Favorable Safety Profile In HPV+ Solid Tumors
December 02, 2021
Tickers
SQZ
Tags
Biotech
Trading Ideas
Benzinga
From
Benzinga
ARCA Biopharma Expects Data Readout From Mid-Stage COVID-19 Trial In Q1 2022
December 02, 2021
Tickers
ABIO
Tags
Briefs
General
Health Care
From
Benzinga
FDA Signs Off Chemomab's Lead Candidate Mid-Stage Study In Bile Duct Disease
December 02, 2021
Tickers
CMMB
Tags
News
Briefs
General
From
Benzinga
VBI Vaccines Reveals Updated Overall Survival Data From Brain Cancer Vaccine Trial
December 02, 2021
Tickers
GSK
VBIV
Tags
News
Small Cap
Brain Tumor
From
Benzinga
Inhibrx Precision Cancer Antibody Receives FDA Orphan Drug Tag For Rare Bone Cancer
December 02, 2021
Tickers
INBX
Tags
Health Care
Phase 2 Trial
FDA
From
Benzinga
Clene's Amyotrophic Lateral Sclerosis Candidate Shows Favorable Impact On Disease Progression
December 01, 2021
Tickers
CLNN
Tags
Health Care
Trading Ideas
Benzinga
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.